~~<i id='82F876DF33'><strike id='82F876DF33'><tt id='82F876DF33'><pre id='82F876DF33'></pre></tt></strike></i>~~

Home» knowledge» hotspot

hotspot

author：entertainment 2025-09-28 22:20:53 Page View：79572

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Think you might have Covid
Next article： Activists slam private health insurers over coverage restrictions

explore

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

YichuanCao/SipaUSAviaAPImagesGileadSciencessaidMondaythatTrodelvy,its“smart-bomb”medicinethatcombine

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

New brain studies show LSD's effects on the brain in full color

AlexHogan/STATWhenLSDwasmadeillegalinthelate1960s,mostlaboratoryresearchonthedrugwaslikewise suspend

WSS

hotspot

hotspot

focus

explore

New brain studies show LSD's effects on the brain in full color